Junichi Matsuo

5PUBLICATIONS
49CO-AUTHORS
Haematological tumoursCancer cell biologyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 20, 2025
An Upstream RUNX3 Enhancer, eR3 (-18m/-28h), Regulates the Development of Gut-Associated Anti-Tumorigenic CD8+CD103+ Cytotoxic T Lymphocytes in Mouse and Human.

Giselle Sek Suan Nah, Junichi Matsuo, Avinash Govind Bahirvani

|Oct 22, 2024
IQGAP3 signalling mediates intratumoral functional heterogeneity to enhance malignant growth.

Mitsuhiro Shimura, Junichi Matsuo, ShuChin Pang

|Jan 19, 2024
Aberrant Upregulation of RUNX3 Activates Developmental Genes to Drive Metastasis in Gastric Cancer.

Kazuto Suda, Atsushi Okabe, Junichi Matsuo

|Jul 03, 2023
RUNX3 inactivates oncogenic MYC through disruption of MYC/MAX complex and subsequent recruitment of GSK3β-FBXW7 cascade.

Vincent Oei, Linda Shyue Huey Chuang, Junichi Matsuo

|Jan 16, 2020
DNA damage signalling as an anti-cancer barrier in gastric intestinal metaplasia.

Vaidehi Krishnan, Debbie Xiu En Lim, Phuong Mai Hoang

Pageof 1

Frequent Collaborators

5 joint publications

Yoshiaki Ito

3 joint publications

Linda Shyue Huey Chuang

3 joint publications

Khay-Guan Yeoh

2 joint publications

Phuong Mai Hoang